Vexev
Develops an autonomous vascular imaging platform that uses robotics and imaging technology to support non-invasive artery scans.
Overview
Vexev builds an autonomous vascular imaging platform for healthcare providers, aiming to improve access to vascular assessment through automated scanning. Its product is positioned for clinical use in non-invasive imaging workflows, with a focus on artery and vascular health. The company raised $6 million in an undisclosed round announced in August 2026. The financing is intended to accelerate U.S. commercialization of its autonomous vascular imaging platform, supporting expansion into a major healthcare market.
Funding History
Vexev Raises $6M to Accelerate U.S. Commercialization of Autonomous Vascular Imaging Platform
Frequently Asked Questions
- How much funding does AI Funding track for Vexev?
- AI Funding tracks $6M for Vexev across 1 funding round in this database.
- What does Vexev do?
- Vexev builds an autonomous vascular imaging platform for healthcare providers, aiming to improve access to vascular assessment through automated scanning. Its product is positioned for clinical use in non-invasive imaging workflows, with a focus on artery and vascular health. The company raised $6 million in an undisclosed round announced in August 2026. The financing is intended to accelerate U.S. commercialization of its autonomous vascular imaging platform, supporting expansion into a major healthcare market.
- Where is Vexev headquartered?
- Vexev is headquartered in Sydney, Australia.
Related Insights
A funding-led map of the Physical AI stack, from real-world data and simulation through autonomy models, robotic systems, validation, and deployment infrastructure.
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.